CLVT Financials: Revenue Breakdown, Margins & Competitor Comparison
Clarivate PLC (CLVT) generates most of its revenue from subscriptions, accounting for 65.1% of total sales. The company exhibits a gross margin of 36.16%, an operating margin of 9.40%, and a net margin of 0.50%. When compared to competitors like STGW and MQ, CLVT's gross margin is competitive within the Professional Information Services industry.
Is Clarivate’s (CLVT) New AI50 Benchmark Quietly Reframing Its Data-Moat Investment Narrative?
Clarivate Plc recently launched the Clarivate AI50 benchmark, ranking 50 leading organizations in AI inventions, which could influence its investment narrative by highlighting its relevance in measuring AI innovation. However, this development does not alter the near-term challenges such as its projected net loss for 2026 and the risk of AI commoditization impacting its pricing power. Investors are advised to consider the company's full narrative and its financial forecasts, which suggest a significant upside to its current price despite potential future competition.
Clarivate (CLVT) director takes $28,750 board retainer in stock award
Clarivate director Kenneth L. Cornick received a quarterly stock award of 11,363 ordinary shares valued at $2.53 per share, totaling $28,750, in lieu of a cash retainer for board service. A portion of these shares (2,273) was withheld for tax obligations. Following this transaction, Cornick directly owns 45,764 ordinary shares and indirectly holds 1,100,000 ordinary shares through an LLC he controls.
Clarivate (CLVT) director gets share grant and tax withholding in Form 4
Clarivate director Andrew Miles Snyder received 20,256 Ordinary Shares as a quarterly award in lieu of a $51,250 cash retainer, at $2.53 per share, under the company's incentive plan. Concurrently, 1,292 shares were withheld for tax obligations. This transaction resulted in Snyder directly holding 211,280 shares, in addition to significant indirect holdings through affiliated entities and a family trust, for which he disclaims beneficial ownership except for his pecuniary interest.
Clarivate (CLVT) director receives 11,363-share grant, 621 withheld for taxes
Clarivate PLC director Jane L Okun Bomba received a grant of 11,363 Ordinary Shares on March 31, 2026, in lieu of a $28,750 cash retainer, with each share valued at $2.53. To cover tax obligations, 621 shares were withheld. Following this transaction, her direct holdings amount to 240,264 Ordinary Shares, complemented by an indirect holding of 49,750 shares through a trust.
Why journals are put on hold in Web of Science Core Collection – and how research integrity guides the process
This article explains why journals are placed "on hold" in the Web of Science Core Collection, a neutral mechanism for review when concerns about quality criteria arise. It details the re-evaluation process, noting that approximately 85% of journals placed on hold are ultimately delisted, and emphasizes the crucial role publishers play in proactively addressing integrity breaches to influence outcomes and maintain trust in scholarly publishing. Clarivate aims to support a trustworthy scholarly record through collaboration and transparent processes.
[ARS] CLARIVATE PLC SEC Filing
This article announces an ARS SEC filing by Clarivate PLC (CLVT), noting a low filing impact and neutral sentiment. The filing was made on April 1, 2026, at 08:08 AM. It provides details on Clarivate's stock performance, recent news, and other SEC filings.
Clarivate (NYSE: CLVT) outlines 2026 vote on board, pay and auditors
Clarivate Plc (NYSE: CLVT) has scheduled its 2026 Annual General Meeting for May 14, 2026, where shareholders will vote on the re-election of ten directors, an advisory approval of 2025 executive compensation, and the ratification of PricewaterhouseCoopers LLP as the independent auditors for 2026. The company emphasizes that nine of its ten director nominees are independent, and all standing committees are fully independent, reinforcing strong corporate governance. Clarivate's executive compensation program is designed to align with shareholder interests, with a significant majority of executive pay being performance-based and at-risk.
Clarivate Unveils AI-Powered Tool for Trademark Risk Assessment
Clarivate has introduced an AI-powered trademark risk assessment solution designed to help companies evaluate logo and word marks efficiently. The tool utilizes machine learning to provide comprehensive assessments, aiming to streamline the trademark clearance process and make smarter legal and business decisions. This innovation includes features like a "Risk Score" and "Similarity Meter" to enhance accuracy and reduce manual work for intellectual property professionals.
Clarivate Updates Executive Severance Plan and Equity Vesting
Clarivate's board approved an Amended and Restated Executive Severance Plan on March 23, 2026, which updates executive protections and explicitly includes the CEO. The updated plan expands severance eligibility for "good reason" terminations tied to a change in control and revises the vesting rules for restricted stock units and performance units. This aims to strengthen leadership retention and alignment during potential corporate transitions.
Clarivate PLC (NYSE:CLVT) Receives Average Recommendation of "Reduce" from Brokerages
Clarivate PLC (NYSE:CLVT) has an average "Reduce" recommendation from eight brokerages, with a mean one-year price target of $3.22. Major firms like Goldman Sachs, Morgan Stanley, and RBC have recently downgraded the stock and cut price targets, reflecting a cautious outlook. Despite this, institutional investors own a significant portion of shares, and some hedge funds have increased their positions.
Clarivate CEO Added as Eligible Participant in Amended Executive Severance Plan
Clarivate (CLVT) has approved an Amended and Restated Executive Severance Plan, effective March 23, 2026, which now explicitly includes the CEO as an eligible participant. The amended plan details vesting and severance provisions for executive-level terminations and largely maintains the terms of the original 2021 plan, with specific adjustments for RSU vesting. This information is based on an SEC filing.
Clarivate Updates Executive Severance Plan and Equity Vesting
Clarivate (CLVT) has updated its Executive Severance Plan, now explicitly including the CEO as an eligible participant and enhancing equity vesting conditions, particularly around change in control events. The revisions aim to strengthen leadership retention and alignment. An AI analysis by TipRanks’ Spark evaluates CLVT as Neutral, citing strong financial execution tempered by a weak longer-term price trend and valuation concerns due to ongoing unprofitability.
Clarivate (NYSE: CLVT) revises change-in-control severance and RSU vesting
Clarivate Plc (NYSE: CLVT) has updated its executive severance plan, effective March 23, 2026, which now explicitly includes the CEO and modifies terms for Restricted Stock Unit (RSU) vesting under qualifying terminations. The revised plan provides for enhanced RSU vesting in cases of a change in control, where all outstanding RSUs will vest fully, and performance-based RSUs vest at a level determined by the HRCC. For non-change-in-control terminations, RSU vesting varies based on grant date and a prorated schedule.
Why structured and categorized research data matter for search, discovery and analytics
This article emphasizes the critical importance of structured and categorized research data for effective search, discovery, and analytics in academia. It highlights how inconsistent or incomplete metadata can lead to misinterpretations of research performance, breakdowns in discovery of less conventional literature, and distorted citation indicators due to un-categorized collaboration effects. The piece advocates for rigorous data curation, taxonomy, and metadata standards to ensure confident decision-making and transparent evaluation within the research community.
Clarivate Reveals the AI50 - the Organizations Leading Artificial Intelligence Invention
Clarivate Plc announced its new AI50 benchmark, identifying organizations with exceptional leadership in high-impact AI inventions, including companies like NVIDIA, Micron Technology, and Alphabet. The report highlights that over half of these AI50 organizations are also featured in the 2026 Top 100 Global Innovators, with a significant concentration in Mainland China, the United States, South Korea, and Japan. The analysis, based on the Derwent Strength Index, shows these organizations are driving foundational AI development, specializing in domain-focused applications, and engaging in high levels of cross-border and academic collaboration.
AI in libraries: sustainability, responsibility, and a practical path forward
This article discusses the responsible adoption of AI in libraries, focusing on sustainability and ethical considerations. It addresses concerns about AI's environmental impact, distinguishing between training intensive models and everyday inference tasks. Furthermore, it outlines how AI can enhance efficiency and sustainability in library operations while emphasizing the critical role of technology partners in minimizing computational load and ensuring transparency.
Clarivate Study Examines Impact of Academic AI on Library Workflows
A new study by Clarivate, conducted by Emerging Strategy, reveals the significant impact of academic AI on library workflows, showing efficiency gains and increased capacity. Key findings indicate a 30-60% reduction in time for manual tasks and a 2-4 times increase in workflow capacity. The study emphasizes AI's role in complementing rather than replacing human library professionals, enabling them to focus on higher-value activities and deepen their community impact.
How AI Cut Library Workflow Time by 30–60%
A new study conducted by Emerging Strategy for Clarivate reveals that AI can reduce manual library workflow time by 30-60%. Academic AI tools like Leganto Syllabus Assistant and Alma AI Metadata Assistant significantly improve efficiency in tasks such as course reading list preparation and metadata creation, allowing libraries to process more work and enhance access to resources. The study emphasizes that AI automates repetitive tasks, enabling librarians to focus on high-value work while maintaining professional judgment and oversight.
CLARIVATE (NYSE: CLVT) President receives 377,358-share stock grant
CLARIVATE PLC's President, A&G Bar Veinstein, received a grant of 377,358 Ordinary Shares as a non-cash compensation award. This grant increased his direct holdings to 1,263,016 Ordinary Shares, aligning his compensation with the company's share performance. The transaction is considered routine and strengthens equity-based incentives without indicating a view on the current share price.
Clarivate (NYSE: CLVT) exec equity grant with tax shares withheld
Clarivate's President, LS&H, Henry Levy, received a grant of 377,358 ordinary shares as compensation on March 15, 2026. A portion of these shares, 35,402, was withheld at $2.57 per share to cover tax obligations related to restricted share unit vesting. Following these transactions, Levy directly owns 1,003,266 ordinary shares, which is noted as routine equity compensation activity rather than open market trading.
Clarivate (NYSE: CLVT) SVP awarded shares, gifts stock to charity
Clarivate PLC Senior VP, Finance/CAO Michael M. Easton received a grant of 282,075 Ordinary Shares and had 30,456 shares withheld for tax purposes related to restricted share unit vesting. Additionally, Easton gifted 26,500 shares to a charitable organization. These transactions reflect share acquisition, tax withholding, and a charitable donation rather than open-market trading.
Clarivate (NYSE: CLVT) CIO receives 254,716-share equity award
Clarivate's Executive Vice President and Chief Information Officer, William E. Graff, received an equity award of 254,716 ordinary shares. Concurrently, 23,838 shares were withheld for tax purposes related to the vesting of restricted share units. Following these transactions, Graff's direct ownership in Clarivate PLC increased to 834,124 ordinary shares.
Clarivate Plc England
Clarivate Plc has released its fourth-quarter and full-year 2025 financial results. The company provided detailed financial statements, including consolidated balance sheets, statements of operations, and cash flows, along with reconciliations of non-GAAP financial measures such as Adjusted EBITDA, Adjusted net income, and Free cash flow. Clarivate also offered a 2026 outlook focusing on forecasted financial performance.
Clarivate (NYSE:CLVT) Stock Price Down 3.7% - Here's Why
Clarivate (NYSE:CLVT) stock experienced a 3.7% drop during mid-day trading on Monday, with significantly reduced trading volume. Analysts have recently trimmed price targets and ratings, resulting in a consensus "Reduce" rating and an average price target of $3.22. Despite institutional investors holding a large percentage of shares and some increasing their positions, the company's fundamentals show a negative P/E ratio and weak liquidity.
Invenomic Capital Management LP Sells 682,042 Shares of Clarivate PLC $CLVT
Invenomic Capital Management LP reduced its stake in Clarivate PLC (NYSE:CLVT) by 7.3%, selling 682,042 shares and retaining 8,703,045 shares valued at $33.3 million. This comes as several analysts have cut their ratings and price targets for Clarivate, contributing to a "Reduce" consensus rating with an average target price of $3.22. Clarivate shares currently trade around $2.58, with a market capitalization of $1.65 billion and a negative P/E ratio.
Is Clarivate (CLVT) Using Claude Integration to Deepen Its Data Moat or Just Follow Hype?
Clarivate Plc (CLVT) recently integrated its Cortellis Regulatory Intelligence data with Anthropic’s Claude, aiming to embed its authoritative regulatory content directly into customer AI workflows. This move supports Clarivate's strategy to maintain the essentiality of its curated data, especially as AI reshapes information services and the company navigates debt reduction and portfolio simplification. While the integration could enhance the perceived value and stickiness of its data platforms, investors should consider the ongoing execution risks, potential for AI-driven commoditization, and the company's efforts to sell its Life Sciences and Healthcare segment.
Cove Street Capital LLC Grows Position in Clarivate PLC $CLVT
Cove Street Capital LLC significantly increased its stake in Clarivate PLC, boosting its holdings by 4,075.2% to 452,462 shares, making it the 16th-largest holding. Other major institutions like Norges Bank, Bank of America, Man Group, and American Century also increased or initiated positions, resulting in institutional ownership of 85.72%. Despite this, Clarivate (NYSE:CLVT) currently trades around $2.58 with a negative P/E, and analysts maintain a "Reduce" rating with an average price target of $3.22.
Clarivate shares climb over 3% after earnings beat and strong outlook
Shares of Clarivate (CLVT) rose over 3% after the company reported better-than-expected fourth-quarter earnings and provided a strong outlook for 2024. The data and analytics provider achieved an adjusted EPS of $0.20, surpassing the analyst consensus of $0.17. Its full-year adjusted EPS guidance of $0.80-$0.85 also exceeded expectations.
Clarivate Claude Tie Up Tests AI Disintermediation And Workflow Stickiness
Clarivate has integrated its regulatory intelligence, Cortellis Regulatory Intelligence (CRI), with Anthropic's Claude AI assistant. This move aims to embed Clarivate's data directly into biopharma, biotech, and medtech AI workflows, positioning its datasets as underlying infrastructure. While this integration could enhance customer stickiness and retention, it also poses risks related to reliance on third-party AI platforms and potential commoditization of data services.
Is Clarivate PLC (CLVT) one of the best penny stocks to buy according to Reddit?
The article discusses whether Clarivate PLC (CLVT) is considered a top penny stock by Reddit users. It explores the company's potential as an investment in the penny stock market, likely referencing online community sentiment.
Is Clarivate Plc (CLVT) One of the Best Penny Stocks to Buy According to Reddit?
Clarivate Plc (CLVT) is identified as a top penny stock on Reddit despite recent price target cuts from Citi and RBC Capital due to concerns about AI disintermediation and a potential segment sale. The company reported reduced revenues in Q4 and full year 2025 compared to 2024, yet it focuses on providing global information and workflow solutions. The article also contains promotional content for an AI stock with high growth potential, suggesting it might outperform CLVT.
Clarivate Expands Access to Trusted Regulatory Intelligence Within Claude
Clarivate Plc announced an integration that will embed its proprietary regulatory intelligence from Cortellis Regulatory Intelligence (CRI) into Anthropic's Claude AI. This collaboration aims to provide biopharma, biotech, medtech, and clinical research organizations with context-aware access to authoritative regulatory data directly within their existing AI workflows. The initiative is part of Clarivate's strategy to extend its insights into enterprise AI ecosystems, combining Claude's natural language understanding with Clarivate's industry-validated sources for faster, more confident regulatory decision-making.
Clarivate Brings Trusted Regulatory Intelligence To Claude's AI Ecosystem
Clarivate (NYSE:CLVT) announced the integration of its Cortellis Regulatory Intelligence (CRI) data with Anthropic's AI assistant, Claude. This integration, utilizing the open Model Context Protocol, provides biopharma, biotech, medtech, and clinical research organizations with direct access to authoritative regulatory information within their existing AI tools. This move aims to enhance decision-making by combining CRI insights with internal and approved external data.
AI that understands regulations: Clarivate feeds life sciences data into Claude
Clarivate (NYSE: CLVT) announced that its Cortellis Regulatory Intelligence (CRI) will integrate with Anthropic's Claude AI via the open Model Context Protocol (MCP). This integration aims to provide life sciences and regulatory teams with intelligent, context-aware access to authoritative regulatory data directly within their AI workflows, offering referenced answers to support faster and more confident decision-making. The partnership builds on Clarivate's strategy to extend its proprietary intelligence into enterprise AI ecosystems, combining industry-validated sources with Claude's natural language understanding and reasoning.
Clarivate Expands Access to Trusted Regulatory Intelligence Within Claude
Clarivate Plc announced an integration to bring its proprietary regulatory intelligence, Cortellis Regulatory Intelligence (CRI), into Anthropic's Claude AI. This collaboration provides biopharma, biotech, medtech, and clinical research organizations with context-aware access to authoritative regulatory data within their existing AI workflows. The CRI Model Context Protocol (MCP) will embed industry-validated regulatory content, combining Claude's natural language understanding with Clarivate's data to support faster, more confident regulatory decision-making.
Clarkston Capital Partners LLC Sells 3,321,993 Shares of Clarivate PLC $CLVT
Clarkston Capital Partners LLC reduced its stake in Clarivate PLC by 4.7% in the third quarter, selling over 3.3 million shares. Despite this, Clarivate remains the fund's third-largest position, representing 10.09% of the company's stock. Clarivate has recently faced analyst downgrades and reduced price targets, with the stock currently trading around $2.74 and holding a "Reduce" consensus rating.
Clarivate (CLVT) Narrows Losses Yet Guides to 2026 Red Ink – What Is the Profit Path?
Clarivate (CLVT) reported narrowed losses in Q4 2025 and for the full year, with net income improving to $3.1 million in Q4 from a significant loss a year prior. Despite reducing goodwill impairment and analysts lifting earnings estimates, the company still projects a net loss for 2026, with revenue guidance between US$2.30 billion and US$2.42 billion and a net loss of US$189 million to US$124 million. This outlook keeps concerns about execution risk, balance sheet pressure, and long-term profitability in focus for investors.
Clarivate (CLVT) Narrows Losses Yet Guides to 2026 Red Ink – What Is the Profit Path?
Clarivate (CLVT) reported narrowed losses in Q4 2025 and for the full year 2025, but its 2026 guidance still projects a net loss. This prompts questions about its path to profitability despite improving analyst estimates and focus on its Intellectual Property Software. The company's high debt load and ongoing net losses remain key concerns for investors, even with some positive quarterly financial results.
Clarivate’s Strong 2026 Guidance Sparks Investor Interest
Clarivate Plc (CLVT) has seen an 8.88% stock increase due to positive investor sentiment driven by strong 2026 fiscal guidance, exceeding EPS expectations and aligning with revenue projections. The company's strategic shift toward subscription-based revenue and operational efficiencies, including AI-driven solutions, has bolstered investor confidence despite mixed profitability indicators and substantial debt. Analysts maintain a neutral sentiment, noting potential for future growth contingent on continued strategic execution and positive market trends.
Clarivate PLC $CLVT Shares Acquired by American Century Companies Inc.
American Century Companies Inc. increased its stake in Clarivate PLC (NYSE:CLVT) by 20.6% in the third quarter, acquiring an additional 1.7 million shares and now holding 9.97 million shares valued at approximately $38.2 million. Clarivate's stock currently trades around $2.74, with a market cap of $1.75 billion and a negative P/E ratio. Wall Street sentiment is reportedly negative, with several recent downgrades and a consensus "Reduce" rating with an average price target of $3.22.
Clarivate Earnings Call: Margins Up, Growth Rebuilding
Clarivate Plc (CLVT) held its Q4 earnings call, achieving full-year guidance for the first time since 2019 and demonstrating improved discipline with strong cash generation. While the company faces revenue headwinds from disposals and soft organic growth, particularly in its IP business, it is rebuilding credibility through better sales execution, product innovation, and cost control. Clarivate is also pursuing a formal sale of its Life Sciences & Health segment to sharpen focus, expecting margin expansion and targeted investment in the remaining businesses.
Surging Earnings Estimates Signal Upside for Clarivate (CLVT) Stock
Clarivate PLC (CLVT) is showing strong potential for investors due to significantly improving earnings estimates. Analysts are consistently raising their estimates for the company, reflecting growing optimism about its financial prospects. This positive trend in revisions, supported by a Zacks Rank #2 (Buy), suggests that CLVT stock could continue its strong performance.
Clarivate to Present at the Wolfe Research FinTech Forum on March 10
Clarivate Plc announced that its Executive Vice President and Chief Financial Officer, Jonathan Collins, will present at the Wolfe Research FinTech Forum on Tuesday, March 10, 2026, at 10:55 am Eastern Time. A live webcast of the presentation will be available, with a replay accessible on Clarivate's investor relations website for 90 days. Clarivate is a global provider of transformative intelligence, offering data, insights, and workflow solutions across Academia & Government, Intellectual Property, and Life Sciences & Healthcare sectors.
Clarivate Stock Has Tanked 42%, and One Fund Just Ditched a $43 Million Stake
HG Vora Capital Management sold its entire 11,125,000 share stake in Clarivate (NYSE:CLVT) during the fourth quarter, representing a $42.61 million position. This move comes as Clarivate's stock has dropped 42% over the past year, while the company attempts a strategic reset to address its significant debt and declining revenue. The fund's exit highlights concerns about Clarivate's financial restructuring despite its subscription-heavy business model.
Clarivate Stock Has Tanked 42%, and One Fund Just Ditched a $43 Million Stake
HG Vora Capital Management sold off its entire $42.61 million stake in Clarivate, totaling 11,125,000 shares, during the fourth quarter. This divestment comes as Clarivate's stock has dropped 42% over the past year, significantly underperforming the S&P 500. The company, which provides subscription-based analytics and information services, is undergoing a strategic reset and is exploring the sale of its Life Sciences segment to reduce its $4.47 billion debt.
Clarivate (NYSE: CLVT) SVP gets share award and withholds stock for tax
Clarivate PLC's Senior VP, Finance/CAO Michael M. Easton reported receiving an award of 4,266 ordinary shares on February 18, 2026, stemming from vested performance share units. Subsequently, on March 1, 2026, he disposed of 27,136 and 704 shares through tax-withholding dispositions at $2.30 per share. Following these transactions, Easton directly holds 474,190 ordinary shares, and the company noted the Form 4 filing was late due to an administrative oversight.
Clarivate finance chief joins Wolfe FinTech Forum with live webcast
Clarivate (NYSE: CLVT) announced that its Executive Vice President and Chief Financial Officer, Jonathan Collins, will present at the Wolfe Research FinTech Forum on March 10, 2026, at 10:55 AM ET. The presentation will be available via a live webcast, with a replay accessible for 90 days. This participation is part of Clarivate's ongoing investor relations efforts, following recent updates on earnings, capital allocation, and AI product initiatives.
Clarivate to Present at the Wolfe Research FinTech Forum on March 10
Clarivate Plc announced that Jonathan Collins, Executive Vice President and Chief Financial Officer, will present at the Wolfe Research FinTech Forum on March 10, 2026, at 10:55 am Eastern Time. A live webcast and replay of the presentation will be available for those interested in the transformative intelligence provider's updates. The replay will be accessible for 90 days on the company's investor relations website.
Clarivate PLC (NYSE:CLVT) Short Interest Up 21.2% in February
Clarivate PLC (NYSE:CLVT) experienced a significant increase in short interest during February, with total short interest growing by 21.2% to 61,217,098 shares. This represents approximately 12.0% of the company's stock being short sold, resulting in a short-interest ratio of 6.4 days based on average daily volume. The article also provides Clarivate's financial metrics, recent analyst ratings, and institutional investor activity.
